SVA
Sinovac Biotech, Ltd.

761
Loading...
Loading...
News
all
press releases
Sinovac Clears Legal Hurdle In Control Battle, Moves Forward With $55 Dividend
A U.S. court denied an emergency injunction sought by dissenting investors, while a separate case in Antigua could unlock an additional $11 per share if disputed PIPE shares are invalidated.
Stocktwits·2mo ago
News Placeholder
More News
News Placeholder
SINOVAC Issues Statement Regarding Privy Council Judgment
Sinovac Biotech Ltd. (NASDAQ:SVA) ('SINOVAC' or the 'Company'), a leading provider of biopharmaceutical products in China, today announced that the Judicial Committee of the Privy Council in London...
Business Wire·8mo ago
News Placeholder
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
Sinovac Biotech Ltd. (SINOVAC or the Company) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today kicked off the enrollment for a Phase III clinical trial on a vaccine...
Business Wire·9mo ago
News Placeholder
SINOVAC Reports Unaudited First Half of 2024 Financial Results
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended June...
Business Wire·1y ago
News Placeholder
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and...
Business Wire·1y ago
News Placeholder
Sinovac Amends Shareholder Rights Plan
Sinovac Biotech Ltd. (Sinovac or the Company) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that its board of directors has amended its shareholder rights...
Business Wire·2y ago
News Placeholder
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, announced today that its Board of Directors (the Board of Directors...
Business Wire·2y ago

Latest SVA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.